Pharmaceutical manufacturer Aspen could provide 10-million dexamethasone tablets within a month, CEO Stephen Saad said on Tuesday.
“Aspen has looked at the short-term needs and can provide 10-million tablets in the next three to four weeks. We would look to ramp up further should there be a need for additional product,” Saad told Reuters without indicating current production volumes. The government has contacted Aspen to source the drug not only for its domestic market but also for rest of the continent, the company said on Monday.The company has asked the government to indicate required volumes across the continent, Saad said. “Once they give us a sense, we can work out the supply,” he added.